Biopolymers Research
Open Access

Nanoparticle synthesis; Anti-solvent precipitation; Active compounds; Biocompatibility; Environmental sustainability; Morphology

Introduction

The synthesis of nanoparticles has become a pivotal area of research due to their unique properties and potential applications across various fields, including medicine, electronics, and environmental science. Traditional methods of nanoparticle synthesis often involve toxic reagents and complex procedures, raising concerns about environmental impact and biocompatibility [1]. In contrast, biopolymer-driven approaches present a promising alternative that leverages the inherent properties of natural polymers to create nanoparticles in a more sustainable manner. Anti-solvent precipitation is a widely utilized technique for synthesizing nanoparticles, where a solute is precipitated from a solution by adding a non-solvent. This process allows for the controlled manipulation of nanoparticle size and morphology by adjusting parameters such as solvent composition, temperature, and concentration. Biopolymers, such as chitosan, alginate, and gelatin, play a crucial role in this synthesis by influencing the solubility and stability of the nanoparticles formed [2]. This article aims to provide a comprehensive overview of the mechanisms involved in biopolymer-driven nanoparticle synthesis via anti-solvent precipitation. We will discuss the roles of various biopolymers and active compounds in determining the properties of the resulting nanoparticles, exploring how these components can be optimized to tailor nanoparticles for specific applications. By integrating the principles of green chemistry and the advantages of biopolymer use, this study seeks to contribute to the advancement of sustainable nanoparticle production methods.

Methodology

Materials and Reagents: Biopolymers chitosan, alginate, gelatin, and other selected natural polymers. Active compounds various bioactive molecules, including antioxidants and antimicrobial agents. Solvents and anti-solvents water, ethanol, acetone, or other suitable non-solvents [3].

Synthesis of Nanoparticles

Preparation of Biopolymer Solutions: Biopolymers were dissolved in a suitable solvent (e.g., aqueous solution) at specific concentrations to create a homogenous solution. Anti-Solvent Precipitation process the biopolymer solution was mixed with an anti-solvent (e.g., ethanol) under controlled conditions [4]. The addition rate of the anti-solvent was adjusted to promote particle formation without immediate precipitation. Incorporation of active compounds active compounds were either dissolved in the biopolymer solution prior to anti-solvent addition or added separately during the precipitation process to achieve desired bioactivity.

Characterization of Nanoparticles

Size and Morphology: The size and morphology of the nanoparticles were characterized using: Dynamic light scattering (DLS) to measure the hydrodynamic diameter of nanoparticles. Scanning electron microscopy (SEM) for surface morphology analysis [5]. Zeta potential measurement to assess the stability and surface charge of the nanoparticles. Spectroscopic analysis: UV-Vis spectroscopy was used to confirm the presence of active compounds within the nanoparticles and assess their optical properties. All experiments were conducted in triplicates, and the results were analyzed statistically using appropriate software to ensure reproducibility and significance.

Results and Discussion

Nanoparticle Formation and Characterization: Successful formation of nanoparticles was achieved through anti-solvent precipitation, with variations in biopolymer concentration leading to differences in particle size and morphology [6]. Size distribution DLS analysis indicated that the average nanoparticle size ranged from 50 to 300 nm, depending on the biopolymer used and the ratio of biopolymer to active compound.

Morphological Observations: TEM images revealed spherical and irregularly shaped nanoparticles, with chitosan-derived nanoparticles displaying a more uniform size compared to those from gelatin. Incorporation of active compounds the presence of active compounds was confirmed through UV-Vis spectroscopy, which showed characteristic absorption peaks corresponding to the bioactive molecules [7, 8]. Nanoparticles loaded with active compounds exhibited enhanced bioactivity, with antimicrobial and antioxidant assays demonstrating improved efficacy compared to unmodified nanoparticles.

Stability and Zeta Potential Analysis: Zeta potential measurements indicated that the nanoparticles possessed a high degree of stability, with values ranging from -30 to -50 mV, suggesting effective electrostatic repulsion among particles [9, 10]. Comparative analysis a comparative study of different biopolymers highlighted that chitosan-based nanoparticles showed superior size uniformity and stability, while alginate-based nanoparticles exhibited larger sizes and less stability.

Conclusion

The study demonstrates the efficacy of biopolymer-driven anti-solvent precipitation as a versatile method for synthesizing nanoparticles with desirable characteristics. By carefully selecting biopolymers and incorporating active compounds, researchers can effectively tailor nanoparticles for specific applications in medicine and industry. The findings underscore the significance of biopolymer selection on nanoparticle morphology, size distribution, and stability. Additionally, the integration of bioactive compounds not only enhances the functional properties of the nanoparticles but also broadens their potential applications in drug delivery, diagnostics, and therapeutic interventions. Future research should focus on optimizing synthesis parameters and exploring the scalability of these techniques for industrial applications. The promising results from this study lay the groundwork for advancing sustainable and biocompatible nanoparticle production methods, paving the way for innovations in various fields, including nanomedicine and material science.

Acknowledgement

None

Conflict of Interest

None

References

1. Ponrouch A, Marchante E, Courty M, Tarascon JM, Palacín MR, et al. (2012) In search of an optimized electrolyte for Na-ion batteries. Energy Environ Sci 5: 8572-8575.

Indexed at, Google Scholar, Crossref

2. Ponrouch A, Monti D, Boschin A, Steen B, Johansson P, et al. (2014) Non-aqueous electrolytes for sodium-ion batteries. J Mater Chem 3: 22-42.

Google Scholar

3. Nitta N, Wu F, Lee JT, Yushin G (2015) Li-ion battery materials: Present and future. Mater Today18: 252-264.

Indexed at, Google Scholar, Crossref

4. Eurostat (2017) Wages and Labour Costs; Statistical Office of the European Union, European Commission: Brussels, Belgium

Google Scholar, Crossref

5. Peters J, Buchholz D, Passerini S, Weil M (2016) Life cycle assessment of sodium-ion batteries. Energy Environ Sci 9: 1744-1751.

Indexed at, Google Scholar

6. Barker J (2017) Progress in the commercialization of faradion’s Na-ion battery technology, 4th international conference on sodium batteries. Tokyo, Japan 28-30.

Google Scholar

7. Bauer A, Song J, Vail S, Pan W, Barker J, et al. (2018) The scale-up and commercialization of non-aqueous Na-ion battery technologies. Adv Energy Mater 8: 1702869.

Indexed at, Google Scholar, Crossref

8. Benjamin Achzet CH (2013) How to evaluate raw material supply risks-an overview. Resour Pol 38: 435-447.

Indexed at, Google Scholar, Crossref

9. Qin Z, Jia X, Liu Q, Kong B, Wang H, et al. (2020) Enhancing physical properties of chitosan/pullulan electrospinning nanofibers via green crosslinking strategies. Carbohydr Polym 247: 116734.

Indexed at, Google Scholar, Crossref

10. Kalantari K, Afifi AM, Jahangirian H, Webster TJ (2019) Biomedical applications of chitosan electrospun nanofibers as a green polymer—Review. Carbohydr Polym 207: 588-600.

Indexed at, Google Scholar, Crossref